Cigna Group $CI Stock: Foster Victor Wealth Advisors LLC Raises Position

Foster Victor Wealth Advisors LLC grew its stake in Cigna Group (NYSE:CI) by 4.5% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 57,148 shares of the health services provider’s stock after buying an additional 2,482 shares during the period. Foster Victor Wealth Advisors LLC’s holdings in Cigna Group were worth $17,059,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of CI. BlackRock Inc. raised its stake in Cigna Group by 3.7% during the 2nd quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider’s stock worth $6,461,457,000 after acquiring an additional 840,098 shares in the last quarter. GQG Partners LLC purchased a new stake in Cigna Group in the second quarter valued at $1,628,918,000. Bank of America Corp DE lifted its position in Cigna Group by 8.8% in the first quarter. Bank of America Corp DE now owns 3,182,083 shares of the health services provider’s stock valued at $848,821,000 after acquiring an additional 256,677 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in Cigna Group by 10.8% in the first quarter. Dimensional Fund Advisors LP now owns 2,426,218 shares of the health services provider’s stock valued at $647,008,000 after acquiring an additional 236,340 shares during the last quarter. Finally, Legal & General Group Plc acquired a new position in Cigna Group in the second quarter valued at $542,779,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

Cigna Group Stock Performance

Shares of CI opened at $304.74 on Thursday. The company’s 50 day simple moving average is $280.49 and its 200-day simple moving average is $282.73. The firm has a market cap of $80.53 billion, a PE ratio of 12.61, a price-to-earnings-growth ratio of 1.03 and a beta of 0.29. Cigna Group has a 12-month low of $239.51 and a 12-month high of $311.34. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm had revenue of $71.56 billion during the quarter, compared to the consensus estimate of $70.14 billion. During the same quarter in the prior year, the firm earned $7.20 EPS. Cigna Group’s revenue for the quarter was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, equities analysts predict that Cigna Group will post 30.50 EPS for the current year.

Insider Buying and Selling at Cigna Group

In other news, insider Everett Neville sold 617 shares of the company’s stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the sale, the insider directly owned 5,053 shares of the company’s stock, valued at approximately $1,435,304.65. This represents a 10.88% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 19,436 shares of the company’s stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the completion of the sale, the insider directly owned 27,256 shares of the company’s stock, valued at $7,530,015.12. The trade was a 41.63% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 22,730 shares of company stock worth $6,293,359 over the last three months. 0.60% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

CI has been the topic of several research reports. Jefferies Financial Group lowered Cigna Group from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $336.00 to $307.00 in a report on Tuesday, August 4th. Sanford C. Bernstein reiterated an “outperform” rating on shares of Cigna Group in a research report on Friday, October 2nd. Royal Bank Of Canada reissued an “outperform” rating and issued a $337.00 target price on shares of Cigna Group in a report on Thursday, October 1st. Robert W. Baird set a $362.00 target price on Cigna Group in a research report on Friday, July 31st. Finally, Wells Fargo & Company upped their target price on Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a research report on Friday, July 31st. Fifteen investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat.com, Cigna Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $338.24.

Cigna Group Company Profile

The Cigna Group (NYSE: CI) is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.

The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.